Press Release

909, 2026

Creative Biolabs expands advanced single-cell multi-omics and RNA sequencing solutions to support biomedical discovery

September 9th, 2026|

Designed to meet the escalating demand for high-resolution cellular profiling, the upgraded suite offers end-to-end services ranging from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, empowering global researchers across oncology, immunology, and neuroscience. As life science research ...

309, 2026

New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It

September 3rd, 2026|

Guide RNAs from RNA-targeting CRISPR systems remain bound to their target mRNA after total RNA preparations and suppress conventional reverse transcription. uMRT's strand-displacing reverse transcriptase restores accurate knockdown quantification. RNAConnect, a life science company providing next- generation tools to ...

209, 2026

Lexogen Expands NGS Services with GCLP-Compliant Workflows

September 2nd, 2026|

Lexogen, a specialist in RNA sequencing technologies and next-generation sequencing services, announces the availability of designated NGS service workflows operated in compliance with the principles of the World Health Organization's Good Clinical Laboratory Practice guidance. The offering is designed for clinical research and clinical-trial projects requiring ...

2306, 2026

EclipseBio expands eCOMPASS™ platform with eSENSE Break™ to map RNA fragmentation at nucleotide resolution

June 23rd, 2026|

Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-enabled design for RNA therapeutics, today announced the launch of eSENSE Break™, a sequencing-based technology that maps RNA fragmentation and circular RNA nicking sites at single-nucleotide resolution. Standard RNA integrity ...

1906, 2026

Alithea Genomics launches early access program for MERCURIUS™ 1536 DRUG-seq, bringing transcriptomics to compound screening scale

June 19th, 2026|

New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Genomics has announced the early access launch of MERCURIUS™ 1536 DRUG-seq, a new ultra-high-throughput transcriptomics kit designed to help drug discovery teams profile ...

Publications Trend

Submit a Post to the Blog

SUBMIT CONTENT

Subscribe to the RNA-Seq Blog

RNA-Seq Products & Services

Go to Top